Global Osteoarthritis Pain Drugs Market Growth 2021-2026
  • ID: 100238
  • February 4, 2021
  • 176 pages
  • LP Information

According to this latest study, the 2020 growth of Osteoarthritis Pain Drugs will have significant change from previous year. By the most conservative estimates of global Osteoarthritis Pain Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 8115 million in 2019. Over the next five years the Osteoarthritis Pain Drugs market will register a 5.9% CAGR in terms of revenue, the global market size will reach US$ 10220 million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Osteoarthritis Pain Drugs market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Oral
Injection
External

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Medical Care
Personal Care

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Sino Biopharmaceutical
Chugai Pharmaceutical
Pfizer
Mikasa Seiyaku
Bayer
Haohai Biological
SK Chemicals
Taisho Pharmaceutical
Zhejiang Chengyi Pharmaceutical
Freda
Bright Future
Jingfeng Pharmaceutical
Seikagaku Corporation
GSK
Sanofi
Crystal Genomics
Johnson & Johnson
GlaxoSmithKline
Mylan
Lilly
Abbott Laboratories
Almatica Pharma
TEVA
Iroko Pharmaceuticals

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Osteoarthritis Pain Drugs Consumption 2016-2026
2.1.2 Osteoarthritis Pain Drugs Consumption CAGR by Region
2.2 Osteoarthritis Pain Drugs Segment by Type
2.2.1 Oral
2.2.2 Injection
2.2.3 External
2.3 Osteoarthritis Pain Drugs Sales by Type
2.3.1 Global Osteoarthritis Pain Drugs Sales Market Share by Type (2016-2021)
2.3.2 Global Osteoarthritis Pain Drugs Revenue and Market Share by Type (2016-2021)
2.3.3 Global Osteoarthritis Pain Drugs Sale Price by Type (2016-2021)
2.4 Osteoarthritis Pain Drugs Segment by Application
2.4.1 Medical Care
2.4.2 Personal Care
2.5 Osteoarthritis Pain Drugs Sales by Application
2.5.1 Global Osteoarthritis Pain Drugs Sale Market Share by Application (2016-2021)
2.5.2 Global Osteoarthritis Pain Drugs Revenue and Market Share by Application (2016-2021)
2.5.3 Global Osteoarthritis Pain Drugs Sale Price by Application (2016-2021)

3 Global Osteoarthritis Pain Drugs by Company
3.1 Global Osteoarthritis Pain Drugs Sales Market Share by Company
3.1.1 Global Osteoarthritis Pain Drugs Sales by Company (2019-2021)
3.1.2 Global Osteoarthritis Pain Drugs Sales Market Share by Company (2019-2021)
3.2 Global Osteoarthritis Pain Drugs Revenue Market Share by Company
3.2.1 Global Osteoarthritis Pain Drugs Revenue by Company (2019-2021)
3.2.2 Global Osteoarthritis Pain Drugs Revenue Market Share by Company (2019-2021)
3.3 Global Osteoarthritis Pain Drugs Sale Price by Company
3.4 Global Manufacturers Osteoarthritis Pain Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Osteoarthritis Pain Drugs Product Location Distribution
3.4.2 Players Osteoarthritis Pain Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Osteoarthritis Pain Drugs by Region
4.1 Global Osteoarthritis Pain Drugs by Region
4.1.1 Global Osteoarthritis Pain Drugs Sales by Region
4.1.2 Global Osteoarthritis Pain Drugs Revenue by Region
4.2 Americas Osteoarthritis Pain Drugs Sales Growth
4.3 APAC Osteoarthritis Pain Drugs Sales Growth
4.4 Europe Osteoarthritis Pain Drugs Sales Growth
4.5 Middle East & Africa Osteoarthritis Pain Drugs Sales Growth

5 Americas
5.1 Americas Osteoarthritis Pain Drugs Sales by Country
5.1.1 Americas Osteoarthritis Pain Drugs Sales by Country (2016-2021)
5.1.2 Americas Osteoarthritis Pain Drugs Revenue by Country (2016-2021)
5.2 Americas Osteoarthritis Pain Drugs Sales by Type
5.3 Americas Osteoarthritis Pain Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Osteoarthritis Pain Drugs Sales by Region
6.1.1 APAC Osteoarthritis Pain Drugs Sales by Region (2016-2021)
6.1.2 APAC Osteoarthritis Pain Drugs Revenue by Region (2016-2021)
6.2 APAC Osteoarthritis Pain Drugs Sales by Type
6.3 APAC Osteoarthritis Pain Drugs Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Osteoarthritis Pain Drugs by Country
7.1.1 Europe Osteoarthritis Pain Drugs Sales by Country (2016-2021)
7.1.2 Europe Osteoarthritis Pain Drugs Revenue by Country (2016-2021)
7.2 Europe Osteoarthritis Pain Drugs Sales by Type
7.3 Europe Osteoarthritis Pain Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Osteoarthritis Pain Drugs by Country
8.1.1 Middle East & Africa Osteoarthritis Pain Drugs Sales by Country (2016-2021)
8.1.2 Middle East & Africa Osteoarthritis Pain Drugs Revenue by Country (2016-2021)
8.2 Middle East & Africa Osteoarthritis Pain Drugs Sales by Type
8.3 Middle East & Africa Osteoarthritis Pain Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Osteoarthritis Pain Drugs Distributors
10.3 Osteoarthritis Pain Drugs Customer

11 Global Osteoarthritis Pain Drugs Market Forecast
11.1 Global Osteoarthritis Pain Drugs Forecast by Region
11.1.1 Global Osteoarthritis Pain Drugs Forecast by Regions (2021-2026)
11.2.2 Global Osteoarthritis Pain Drugs Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Countries
11.3 APAC Forecast by Region
11.4 Europe Forecast by Countries
11.5 Middle East & Africa Forecast by Countries
11.6 Global Osteoarthritis Pain Drugs Forecast by Type
11.7 Global Osteoarthritis Pain Drugs Forecast by Application

12 Key Players Analysis
12.1 Sino Biopharmaceutical
12.1.1 Sino Biopharmaceutical Sino Biopharmaceutical Company Information
12.1.2 Sino Biopharmaceutical Osteoarthritis Pain Drugs Product Offered
12.1.3 Sino Biopharmaceutical Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Sino Biopharmaceutical Main Business Overview
12.1.5 Sino Biopharmaceutical Latest Developments
12.2 Chugai Pharmaceutical
12.2.1 Chugai Pharmaceutical Company Information
12.2.2 Chugai Pharmaceutical Osteoarthritis Pain Drugs Product Offered
12.2.3 Chugai Pharmaceutical Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Chugai Pharmaceutical Main Business Overview
12.2.5 Chugai Pharmaceutical Latest Developments
12.3 Pfizer
12.3.1 Pfizer Company Information
12.3.2 Pfizer Osteoarthritis Pain Drugs Product Offered
12.3.3 Pfizer Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Pfizer Main Business Overview
12.3.5 Pfizer Latest Developments
12.4 Mikasa Seiyaku
12.4.1 Mikasa Seiyaku Company Information
12.4.2 Mikasa Seiyaku Osteoarthritis Pain Drugs Product Offered
12.4.3 Mikasa Seiyaku Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Mikasa Seiyaku Main Business Overview
12.4.5 Mikasa Seiyaku Latest Developments
12.5 Bayer
12.5.1 Bayer Company Information
12.5.2 Bayer Osteoarthritis Pain Drugs Product Offered
12.5.3 Bayer Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Bayer Main Business Overview
12.5.5 Bayer Latest Developments
12.6 Haohai Biological
12.6.1 Haohai Biological Company Information
12.6.2 Haohai Biological Osteoarthritis Pain Drugs Product Offered
12.6.3 Haohai Biological Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Haohai Biological Main Business Overview
12.6.5 Haohai Biological Latest Developments
12.7 SK Chemicals
12.7.1 SK Chemicals Company Information
12.7.2 SK Chemicals Osteoarthritis Pain Drugs Product Offered
12.7.3 SK Chemicals Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 SK Chemicals Main Business Overview
12.7.5 SK Chemicals Latest Developments
12.8 Taisho Pharmaceutical
12.8.1 Taisho Pharmaceutical Company Information
12.8.2 Taisho Pharmaceutical Osteoarthritis Pain Drugs Product Offered
12.8.3 Taisho Pharmaceutical Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Taisho Pharmaceutical Main Business Overview
12.8.5 Taisho Pharmaceutical Latest Developments
12.9 Zhejiang Chengyi Pharmaceutical
12.9.1 Zhejiang Chengyi Pharmaceutical Company Information
12.9.2 Zhejiang Chengyi Pharmaceutical Osteoarthritis Pain Drugs Product Offered
12.9.3 Zhejiang Chengyi Pharmaceutical Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Zhejiang Chengyi Pharmaceutical Main Business Overview
12.9.5 Zhejiang Chengyi Pharmaceutical Latest Developments
12.10 Freda
12.10.1 Freda Company Information
12.10.2 Freda Osteoarthritis Pain Drugs Product Offered
12.10.3 Freda Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Freda Main Business Overview
12.10.5 Freda Latest Developments
12.11 Bright Future
12.11.1 Bright Future Company Information
12.11.2 Bright Future Osteoarthritis Pain Drugs Product Offered
12.11.3 Bright Future Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 Bright Future Main Business Overview
12.11.5 Bright Future Latest Developments
12.12 Jingfeng Pharmaceutical
12.12.1 Jingfeng Pharmaceutical Company Information
12.12.2 Jingfeng Pharmaceutical Osteoarthritis Pain Drugs Product Offered
12.12.3 Jingfeng Pharmaceutical Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 Jingfeng Pharmaceutical Main Business Overview
12.12.5 Jingfeng Pharmaceutical Latest Developments
12.13 Seikagaku Corporation
12.13.1 Seikagaku Corporation Company Information
12.13.2 Seikagaku Corporation Osteoarthritis Pain Drugs Product Offered
12.13.3 Seikagaku Corporation Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.13.4 Seikagaku Corporation Main Business Overview
12.13.5 Seikagaku Corporation Latest Developments
12.14 GSK
12.14.1 GSK Company Information
12.14.2 GSK Osteoarthritis Pain Drugs Product Offered
12.14.3 GSK Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.14.4 GSK Main Business Overview
12.14.5 GSK Latest Developments
12.15 Sanofi
12.15.1 Sanofi Company Information
12.15.2 Sanofi Osteoarthritis Pain Drugs Product Offered
12.15.3 Sanofi Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.15.4 Sanofi Main Business Overview
12.15.5 Sanofi Latest Developments
12.16 Crystal Genomics
12.16.1 Crystal Genomics Company Information
12.16.2 Crystal Genomics Osteoarthritis Pain Drugs Product Offered
12.16.3 Crystal Genomics Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.16.4 Crystal Genomics Main Business Overview
12.16.5 Crystal Genomics Latest Developments
12.17 Johnson & Johnson
12.17.1 Johnson & Johnson Company Information
12.17.2 Johnson & Johnson Osteoarthritis Pain Drugs Product Offered
12.17.3 Johnson & Johnson Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.17.4 Johnson & Johnson Main Business Overview
12.17.5 Johnson & Johnson Latest Developments
12.18 GlaxoSmithKline
12.18.1 GlaxoSmithKline Company Information
12.18.2 GlaxoSmithKline Osteoarthritis Pain Drugs Product Offered
12.18.3 GlaxoSmithKline Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.18.4 GlaxoSmithKline Main Business Overview
12.18.5 GlaxoSmithKline Latest Developments
12.19 Mylan
12.19.1 Mylan Company Information
12.19.2 Mylan Osteoarthritis Pain Drugs Product Offered
12.19.3 Mylan Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.19.4 Mylan Main Business Overview
12.19.5 Mylan Latest Developments
12.20 Lilly
12.20.1 Lilly Company Information
12.20.2 Lilly Osteoarthritis Pain Drugs Product Offered
12.20.3 Lilly Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.20.4 Lilly Main Business Overview
12.20.5 Lilly Latest Developments
12.21 Abbott Laboratories
12.21.1 Abbott Laboratories Company Information
12.21.2 Abbott Laboratories Osteoarthritis Pain Drugs Product Offered
12.21.3 Abbott Laboratories Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.21.4 Abbott Laboratories Main Business Overview
12.21.5 Abbott Laboratories Latest Developments
12.22 Almatica Pharma
12.22.1 Almatica Pharma Company Information
12.22.2 Almatica Pharma Osteoarthritis Pain Drugs Product Offered
12.22.3 Almatica Pharma Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.22.4 Almatica Pharma Main Business Overview
12.22.5 Almatica Pharma Latest Developments
12.23 TEVA
12.23.1 TEVA Company Information
12.23.2 TEVA Osteoarthritis Pain Drugs Product Offered
12.23.3 TEVA Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.23.4 TEVA Main Business Overview
12.23.5 TEVA Latest Developments
12.24 Iroko Pharmaceuticals
12.24.1 Iroko Pharmaceuticals Company Information
12.24.2 Iroko Pharmaceuticals Osteoarthritis Pain Drugs Product Offered
12.24.3 Iroko Pharmaceuticals Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.24.4 Iroko Pharmaceuticals Main Business Overview
12.24.5 Iroko Pharmaceuticals Latest Developments

13 Research Findings and Conclusion

None

None

List of Tables
Table 1. Osteoarthritis Pain Drugs Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Oral
Table 3. Major Players of Injection
Table 4. Major Players of External
Table 5. Global Osteoarthritis Pain Drugs Sales by Type (2016-2021) & (M Dose)
Table 6. Global Osteoarthritis Pain Drugs Sales Market Share by Type (2016-2021)
Table 7. Global Osteoarthritis Pain Drugs Revenue by Type (2016-2021) & ($ million)
Table 8. Global Osteoarthritis Pain Drugs Revenue Market Share by Type (2016-2021)
Table 9. Global Osteoarthritis Pain Drugs Sale Price by Type (2016-2021)
Table 10. Global Osteoarthritis Pain Drugs Sales by Application (2016-2021) & (M Dose)
Table 11. Global Osteoarthritis Pain Drugs Sales Market Share by Application (2016-2021)
Table 12. Global Osteoarthritis Pain Drugs Value by Application (2016-2021)
Table 13. Global Osteoarthritis Pain Drugs Revenue Market Share by Application (2016-2021)
Table 14. Global Osteoarthritis Pain Drugs Sale Price by Application (2016-2021)
Table 15. Global Osteoarthritis Pain Drugs Sales by Company (2019-2021) & (M Dose)
Table 16. Global Osteoarthritis Pain Drugs Sales Market Share by Company (2019-2021)
Table 17. Global Osteoarthritis Pain Drugs Revenue by Company (2019-2021) ($ Millions)
Table 18. Global Osteoarthritis Pain Drugs Revenue Market Share by Company (2019-2021)
Table 19. Global Osteoarthritis Pain Drugs Sale Price by Company (2019-2021)
Table 20. Key Manufacturers Osteoarthritis Pain Drugs Producing Area Distribution and Sales Area
Table 21. Players Osteoarthritis Pain Drugs Products Offered
Table 22. Osteoarthritis Pain Drugs Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Osteoarthritis Pain Drugs Sales by Region (2016-2021) (M Dose)
Table 26. Global Osteoarthritis Pain Drugs Sales Market Share by Region (2016-2021)
Table 27. Global Osteoarthritis Pain Drugs Revenue by Region (2016-2021) & ($ Millions)
Table 28. Global Osteoarthritis Pain Drugs Revenue Market Share by Region (2016-2021)
Table 29. Americas Osteoarthritis Pain Drugs Sales by Country (2016-2021) & (M Dose)
Table 30. Americas Osteoarthritis Pain Drugs Sales Market Share by Country (2016-2021)
Table 31. Americas Osteoarthritis Pain Drugs Revenue by Country (2016-2021) & ($ Millions)
Table 32. Americas Osteoarthritis Pain Drugs Revenue Market Share by Country (2016-2021)
Table 33. Americas Osteoarthritis Pain Drugs Sales by Type (2016-2021) & (M Dose)
Table 34. Americas Osteoarthritis Pain Drugs Sales Market Share by Type (2016-2021)
Table 35. Americas Osteoarthritis Pain Drugs Sales by Application (2016-2021) & (M Dose)
Table 36. Americas Osteoarthritis Pain Drugs Sales Market Share by Application (2016-2021)
Table 37. APAC Osteoarthritis Pain Drugs Sales by Region (2016-2021) & (M Dose)
Table 38. APAC Osteoarthritis Pain Drugs Sales Market Share by Region (2016-2021)
Table 39. APAC Osteoarthritis Pain Drugs Revenue by Region (2016-2021) & ($ Millions)
Table 40. APAC Osteoarthritis Pain Drugs Revenue Market Share by Region (2016-2021)
Table 41. APAC Osteoarthritis Pain Drugs Sales by Type (2016-2021) & (M Dose)
Table 42. APAC Osteoarthritis Pain Drugs Sales Market Share by Type (2016-2021)
Table 43. APAC Osteoarthritis Pain Drugs Sales by Application (2016-2021) & (M Dose)
Table 44. APAC Osteoarthritis Pain Drugs Sales Market Share by Application (2016-2021)
Table 45. Europe Osteoarthritis Pain Drugs Sales by Country (2016-2021) & (M Dose)
Table 46. Europe Osteoarthritis Pain Drugs Sales Market Share by Country (2016-2021)
Table 47. Europe Osteoarthritis Pain Drugs Revenue by Country (2016-2021) & ($ Millions)
Table 48. Europe Osteoarthritis Pain Drugs Revenue Market Share by Country (2016-2021)
Table 49. Europe Osteoarthritis Pain Drugs Sales by Type (2016-2021) & (M Dose)
Table 50. Europe Osteoarthritis Pain Drugs Sales Market Share by Type (2016-2021)
Table 51. Europe Osteoarthritis Pain Drugs Sales by Application (2016-2021) & (M Dose)
Table 52. Europe Osteoarthritis Pain Drugs Sales Market Share by Application (2016-2021)
Table 53. Middle East & Africa Osteoarthritis Pain Drugs Sales by Country (2016-2021) & (M Dose)
Table 54. Middle East & Africa Osteoarthritis Pain Drugs Sales Market Share by Country (2016-2021)
Table 55. Middle East & Africa Osteoarthritis Pain Drugs Revenue by Country (2016-2021) & ($ Millions)
Table 56. Middle East & Africa Osteoarthritis Pain Drugs Revenue Market Share by Country (2016-2021)
Table 57. Middle East & Africa Osteoarthritis Pain Drugs Sales by Type (2016-2021) & (M Dose)
Table 58. Middle East & Africa Osteoarthritis Pain Drugs Sales Market Share by Type (2016-2021)
Table 59. Middle East & Africa Osteoarthritis Pain Drugs Sales by Application (2016-2021) & (M Dose)
Table 60. Middle East & Africa Osteoarthritis Pain Drugs Sales Market Share by Application (2016-2021)
Table 61. Global Osteoarthritis Pain Drugs Sales Forecast by Type (2021-2026) & (M Dose)
Table 62. Global Osteoarthritis Pain Drugs Sales Market Share Forecast by Type (2021-2026)
Table 63. Global Osteoarthritis Pain Drugs Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 64. Global Osteoarthritis Pain Drugs Revenue Market Share Forecast by Type (2021-2026)
Table 65. Global Osteoarthritis Pain Drugs Sales Forecast by Application (2021-2026) & (M Dose)
Table 66. Global Osteoarthritis Pain Drugs Sales Market Share Forecast by Application (2021-2026)
Table 67. Global Osteoarthritis Pain Drugs Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 68. Global Osteoarthritis Pain Drugs Revenue Market Share Forecast by Application (2021-2026)
Table 69. Sino Biopharmaceutical Basic Information, Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors
Table 70. Sino Biopharmaceutical Osteoarthritis Pain Drugs Product Offered
Table 71. Sino Biopharmaceutical Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 72. Sino Biopharmaceutical Main Business
Table 73. Sino Biopharmaceutical Latest Developments
Table 74. Chugai Pharmaceutical Basic Information, Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors
Table 75. Chugai Pharmaceutical Osteoarthritis Pain Drugs Product Offered
Table 76. Chugai Pharmaceutical Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 77. Chugai Pharmaceutical Main Business
Table 78. Chugai Pharmaceutical Latest Developments
Table 79. Pfizer Basic Information, Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors
Table 80. Pfizer Osteoarthritis Pain Drugs Product Offered
Table 81. Pfizer Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 82. Pfizer Main Business
Table 83. Pfizer Latest Developments
Table 84. Mikasa Seiyaku Basic Information, Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors
Table 85. Mikasa Seiyaku Osteoarthritis Pain Drugs Product Offered
Table 86. Mikasa Seiyaku Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 87. Mikasa Seiyaku Main Business
Table 88. Mikasa Seiyaku Latest Developments
Table 89. Bayer Basic Information, Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors
Table 90. Bayer Osteoarthritis Pain Drugs Product Offered
Table 91. Bayer Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 92. Bayer Main Business
Table 93. Bayer Latest Developments
Table 94. Haohai Biological Basic Information, Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors
Table 95. Haohai Biological Osteoarthritis Pain Drugs Product Offered
Table 96. Haohai Biological Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 97. Haohai Biological Main Business
Table 98. Haohai Biological Latest Developments
Table 99. SK Chemicals Basic Information, Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors
Table 100. SK Chemicals Osteoarthritis Pain Drugs Product Offered
Table 101. SK Chemicals Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 102. SK Chemicals Main Business
Table 103. SK Chemicals Latest Developments
Table 104. Taisho Pharmaceutical Basic Information, Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors
Table 105. Taisho Pharmaceutical Osteoarthritis Pain Drugs Product Offered
Table 106. Taisho Pharmaceutical Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 107. Taisho Pharmaceutical Main Business
Table 108. Taisho Pharmaceutical Latest Developments
Table 109. Zhejiang Chengyi Pharmaceutical Basic Information, Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors
Table 110. Zhejiang Chengyi Pharmaceutical Osteoarthritis Pain Drugs Product Offered
Table 111. Zhejiang Chengyi Pharmaceutical Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 112. Zhejiang Chengyi Pharmaceutical Main Business
Table 113. Zhejiang Chengyi Pharmaceutical Latest Developments
Table 114. Freda Basic Information, Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors
Table 115. Freda Osteoarthritis Pain Drugs Product Offered
Table 116. Freda Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 117. Freda Main Business
Table 118. Freda Latest Developments
Table 119. Bright Future Basic Information, Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors
Table 120. Bright Future Osteoarthritis Pain Drugs Product Offered
Table 121. Bright Future Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 122. Bright Future Main Business
Table 123. Bright Future Latest Developments
Table 124. Jingfeng Pharmaceutical Basic Information, Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors
Table 125. Jingfeng Pharmaceutical Osteoarthritis Pain Drugs Product Offered
Table 126. Jingfeng Pharmaceutical Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 127. Jingfeng Pharmaceutical Main Business
Table 128. Jingfeng Pharmaceutical Latest Developments
Table 129. Seikagaku Corporation Basic Information, Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors
Table 130. Seikagaku Corporation Osteoarthritis Pain Drugs Product Offered
Table 131. Seikagaku Corporation Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 132. Seikagaku Corporation Main Business
Table 133. Seikagaku Corporation Latest Developments
Table 134. GSK Basic Information, Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors
Table 135. GSK Osteoarthritis Pain Drugs Product Offered
Table 136. GSK Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 137. GSK Main Business
Table 138. GSK Latest Developments
Table 139. Sanofi Basic Information, Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors
Table 140. Sanofi Osteoarthritis Pain Drugs Product Offered
Table 141. Sanofi Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 142. Sanofi Main Business
Table 143. Sanofi Latest Developments
Table 144. Crystal Genomics Basic Information, Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors
Table 145. Crystal Genomics Osteoarthritis Pain Drugs Product Offered
Table 146. Crystal Genomics Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 147. Crystal Genomics Main Business
Table 148. Crystal Genomics Latest Developments
Table 149. Johnson & Johnson Basic Information, Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors
Table 150. Johnson & Johnson Osteoarthritis Pain Drugs Product Offered
Table 151. Johnson & Johnson Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 152. Johnson & Johnson Main Business
Table 153. Johnson & Johnson Latest Developments
Table 154. GlaxoSmithKline Basic Information, Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors
Table 155. GlaxoSmithKline Osteoarthritis Pain Drugs Product Offered
Table 156. GlaxoSmithKline Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 157. GlaxoSmithKline Main Business
Table 158. GlaxoSmithKline Latest Developments
Table 159. Mylan Basic Information, Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors
Table 160. Mylan Osteoarthritis Pain Drugs Product Offered
Table 161. Mylan Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 162. Mylan Main Business
Table 163. Mylan Latest Developments
Table 164. Lilly Basic Information, Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors
Table 165. Lilly Osteoarthritis Pain Drugs Product Offered
Table 166. Lilly Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 167. Lilly Main Business
Table 168. Lilly Latest Developments
Table 169. Abbott Laboratories Basic Information, Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors
Table 170. Abbott Laboratories Osteoarthritis Pain Drugs Product Offered
Table 171. Abbott Laboratories Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 172. Abbott Laboratories Main Business
Table 173. Abbott Laboratories Latest Developments
Table 174. Almatica Pharma Basic Information, Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors
Table 175. Almatica Pharma Osteoarthritis Pain Drugs Product Offered
Table 176. Almatica Pharma Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 177. Almatica Pharma Main Business
Table 178. Almatica Pharma Latest Developments
Table 179. TEVA Basic Information, Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors
Table 180. TEVA Osteoarthritis Pain Drugs Product Offered
Table 181. TEVA Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 182. TEVA Main Business
Table 183. TEVA Latest Developments
Table 184. Iroko Pharmaceuticals Basic Information, Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors
Table 185. Iroko Pharmaceuticals Osteoarthritis Pain Drugs Product Offered
Table 186. Iroko Pharmaceuticals Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 187. Iroko Pharmaceuticals Main Business
Table 188. Iroko Pharmaceuticals Latest Developments
List of Figures
Figure 1. Picture of Osteoarthritis Pain Drugs
Figure 2. Osteoarthritis Pain Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Osteoarthritis Pain Drugs Sales Growth Rate 2016-2026 (M Dose)
Figure 7. Global Osteoarthritis Pain Drugs Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Osteoarthritis Pain Drugs Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Oral
Figure 10. Product Picture of Injection
Figure 11. Product Picture of External
Figure 12. Global Osteoarthritis Pain Drugs Sales Market Share by Type in 2020
Figure 13. Global Osteoarthritis Pain Drugs Revenue Market Share by Type (2016-2021)
Figure 14. Osteoarthritis Pain Drugs Consumed in Medical Care
Figure 15. Global Osteoarthritis Pain Drugs Market: Medical Care (2016-2021) & (M Dose)
Figure 16. Osteoarthritis Pain Drugs Consumed in Personal Care
Figure 17. Global Osteoarthritis Pain Drugs Market: Personal Care (2016-2021) & (M Dose)
Figure 18. Global Osteoarthritis Pain Drugs Sales Market Share by Application (2016-2021)
Figure 19. Global Osteoarthritis Pain Drugs Revenue Market Share by Application in 2020
Figure 20. Global Osteoarthritis Pain Drugs Revenue Market by Company in 2020 ($ Million)
Figure 21. Global Osteoarthritis Pain Drugs Revenue Market Share by Company in 2020
Figure 22. Global Osteoarthritis Pain Drugs Sales Market Share by Regions (2016-2021)
Figure 23. Global Osteoarthritis Pain Drugs Revenue Market Share by Region in 2020
Figure 24. Americas Osteoarthritis Pain Drugs Sales 2016-2021 (M Dose)
Figure 25. Americas Osteoarthritis Pain Drugs Revenue 2016-2021 ($ Millions)
Figure 26. APAC Osteoarthritis Pain Drugs Sales 2016-2021 (M Dose)
Figure 27. APAC Osteoarthritis Pain Drugs Revenue 2016-2021 ($ Millions)
Figure 28. Europe Osteoarthritis Pain Drugs Sales 2016-2021 (M Dose)
Figure 29. Europe Osteoarthritis Pain Drugs Revenue 2016-2021 ($ Millions)
Figure 30. Middle East & Africa Osteoarthritis Pain Drugs Sales 2016-2021 (M Dose)
Figure 31. Middle East & Africa Osteoarthritis Pain Drugs Revenue 2016-2021 ($ Millions)
Figure 32. Americas Osteoarthritis Pain Drugs Sales Market Share by Country in 2020
Figure 33. Americas Osteoarthritis Pain Drugs Revenue Market Share by Country in 2020
Figure 34. Americas Osteoarthritis Pain Drugs Sales Market Share by Type in 2020
Figure 35. Americas Osteoarthritis Pain Drugs Sales Market Share by Application in 2020
Figure 36. United States Osteoarthritis Pain Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 37. Canada Osteoarthritis Pain Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 38. Mexico Osteoarthritis Pain Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 39. Brazil Osteoarthritis Pain Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 40. APAC Osteoarthritis Pain Drugs Sales Market Share by Region in 2020
Figure 41. APAC Osteoarthritis Pain Drugs Revenue Market Share by Regions in 2020
Figure 42. APAC Osteoarthritis Pain Drugs Sales Market Share by Type in 2020
Figure 43. APAC Osteoarthritis Pain Drugs Sales Market Share by Application in 2020
Figure 44. China Osteoarthritis Pain Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 45. Japan Osteoarthritis Pain Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 46. Korea Osteoarthritis Pain Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 47. Southeast Asia Osteoarthritis Pain Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 48. India Osteoarthritis Pain Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 49. Australia Osteoarthritis Pain Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 50. Europe Osteoarthritis Pain Drugs Sales Market Share by Country in 2020
Figure 51. Europe Osteoarthritis Pain Drugs Revenue Market Share by Country in 2020
Figure 52. Europe Osteoarthritis Pain Drugs Sales Market Share by Type in 2020
Figure 53. Europe Osteoarthritis Pain Drugs Sales Market Share by Application in 2020
Figure 54. Germany Osteoarthritis Pain Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 55. France Osteoarthritis Pain Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 56. UK Osteoarthritis Pain Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 57. Italy Osteoarthritis Pain Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 58. Russia Osteoarthritis Pain Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 59. Middle East & Africa Osteoarthritis Pain Drugs Sales Market Share by Country in 2020
Figure 60. Middle East & Africa Osteoarthritis Pain Drugs Revenue Market Share by Country in 2020
Figure 61. Middle East & Africa Osteoarthritis Pain Drugs Sales Market Share by Type in 2020
Figure 62. Middle East & Africa Osteoarthritis Pain Drugs Sales Market Share by Application in 2020
Figure 63. Egypt Osteoarthritis Pain Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 64. South Africa Osteoarthritis Pain Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 65. Israel Osteoarthritis Pain Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 66. Turkey Osteoarthritis Pain Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 67. GCC Country Osteoarthritis Pain Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles

None

Custom Research

Looking for more specific research study and analysis? Contact our Custom Research Team

Write to Custom Research Team